Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation.

ABSTRACT:

SUBMITTER: Lee JM 

PROVIDER: S-EPMC10293273 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature